1. Arabi Y, Murthy S, Webb S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020;46(5):833-836. doi:10.1007/s00134-020-05955-1
2. Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clinic Rev Allergy Immunol. 2022;1-18. doi:10.1007/s12016-022-08921-5
3. Rodrigues FF, Sa J. COVID-19 infection and arterial hypertension — a reciprocal interaction? J Hypertens. 2022;40(1): e179. doi:10.1097/01.hjh.0000837224.48778.d1
4. Ribeiro AC, Uehara SCDSA. Systemic arterial hypertension as a risk factor for the severe form of COVID-19: scoping review. Revista de saude publica. 2022;56:20. doi:10.11606/s1518-8787.2022056004311
5. Roncon L, Zuin M, Zuliani G, Rigatelli G. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission. Br J Anaesth. 2020;125(2):e254-e255. doi:10.1016/j.bja.2020.04.056
6. Vintila AM, Horumba MM, Miron P, Balan R, Catrangiu MB, Negoescu IA et al. Arterial hypertension and COVID-19 in hospital mortality. J Hypertens. 2022;40(1):e168. doi:10.1097/01.hjh.0000837068.15495.2f
7. Jordan J, Kurschat C, Reuter H. Arterial hypertension. Dtsch Arztebl Int. 2018;115(33-34):557-568. doi:10.3238/arztebl.2018.0557
8. Чазова И. Е., Блинова Н. В., Невзорова В. А., Жернакова Ю. В., Савенков М. П., Ощепкова Е. В. и др. Консенсус экспертов Российского медицинского общества по артериальной гипертонии: артериальная гипертония и COVID-19. Системные гипертензии. 2020;17(3):35-41. doi:10.26442/2075082X.2020.3.200362
9. Kadic F, Begic E, Pasic M, Gavrankapetanovic A, Mujakovic A, Pidro A et al. Arterial hypertension in patients with COVID-19 — neural network model. Acta Inform Med. 2022;30(1):25-28. doi:10.5455/aim.2022.30.25-28
10. Pinto IC, Martins D. Prevalence and risk factors of arterial hypertension: a literature review. J Cardiovasc Med Ther. 2017;1(2):1-7. doi:hdl./10198/16934
11. Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 2020;106(15):1142-1147. doi:10.1136/heartjnl-2020-317062
12. Zhu B, Feng X, Jiang C, Mi S, Yang L, Zhao Z et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study. BMC Infect Dis. 2021;21(1):574. doi:10.1186/s12879-021-06277-3
13. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for COVID-19 severity and fatality: a structured literature review. Infection. 2021;49(1):15-28. doi:10.1007/s15010-020-01509-1
14. Zhang N, Wang C, Zhu F, Mao H, Bai P, Chen LL et al. Risk factors for poor outcomes of diabetes patients with COVID-19: A single-center, retrospective study in early outbreak in China. Front Endocrinol. 2020;11:571037. doi:10.3389/fendo.2020.571037
15. Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X et al. Clinical characteristics and outcomes of patients with severe COVID-19 with diabetes. BMJ Open Diabetes Res Care. 2020;8(1):e001343. doi:10.1136/bmjdrc-2020-001343
16. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529-539. doi:10.1007/s00281-017-0629-x
17. Tong X, Cheng A, Yuan X, Zhong X, Wang H, Zhou W et al. Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study. BMC Infect Dis. 2021;21(1):1236. doi:10.1186/s12879-021-06899-7
18. Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M et al. Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis. Front Med. 2020;7:301. doi:10.3389/fmed.2020.00301
19. Jing Liang J, Liu J, Chen Y, Ye B, Li N, Wang X et al. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus. Diabetes Res and Clin Pract. 2020;167:108351. doi:10.1016/j.diabres.2020.108351
20. Hana C, Aboulenain S, Dewaswala N, Narendran V. Does thrombocytopenia truly correlate with COVID-19 severity? Blood. 2020;136(1):39-40. doi:10.1182/blood-2020-142440
21. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145-148. doi:10.1016/j.cca.2020.03.022
22. Menezes MCS, Pestana DVS, Gameiro GR, da Silva LFF, Baron Ё, Rouby JJ et al. SARS-CoV-2 pneumonia — receptor binding and lung immunopathology: a narrative review. Crit Care. 2021:25(1): 53. doi:10.1186/s13054-020-03399-z
23. Su WL, Lu KC, Chan CY, Chao YC. COVID-19 and the lungs: a review. J Infect Public Health. 2021;14(11):1708-1714. doi:10.1016/j.jiph.2021.09.024
24. Soto A, Quiñones-Laveriano DM, Azañero J, Chumpitaz R, Claros J, Salazar L et al. Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian reference hospital. Plos One. 2022;17(3):e0264789. doi:10.1371/journal.pone.0264789
25. Kafan S, Tadbir Vajargah K, Sheikhvatan M, Tabrizi G, Salimzadeh A, Montazeri M et al. Predicting risk score for mechanical ventilation in hospitalized adult patients suffering from COVID-19. Anesth Pain Med. 2021;1(2):e112424. doi:10.5812/aapm.112424
26. Díaz-Vélez C, Urrunaga-Pastor D, Romero-Cerdán A, Peña-Sánchez ER, Fernández Mogollon JL, Cossio Chafloque JD et al. Risk factors for mortality in hospitalized patients with COVID-19 from three hospitals in Peru: a retrospective cohort study. F1000Research. 2021;10:224. doi:10.12688/f1000research.51474.1
27. Stefan G, Mehedinti AM, Andreiana I, Zugravu AD, Cinca S, Busuioc R et al. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania. Ren Fail. 2021;43(1):49-57. doi:10.1080/0886022X.2020.1853571
28. Morse J, Gay W, Korwek KM, McLean LE, Poland RE, Guy J et al. Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients. Endocrinol Diabetes Metab. 2021;4(4):e00291. doi:10.1002/edm2.291
29. Younossi ZM, Stepanova M, Lam B, Cable R, Felix S, Jeffers T et al. Independent predictors of mortality among patients with NAFLD hospitalized with COVID-19 infection. Hepatol Commun. 2022;6(11):3062-3072. doi:10.1002/hep4.1802
30. Chatterjee NA, Jensen PN, Harris AW, Nguyen DD, Huang HD, Cheng RK et al. Admission respiratory status predicts mortality in COVID-19. Influenza Other Respir Viruses. 2021;15(5):569-579. doi:10.1111/irv.12869